Aurobindo Pharma
Aurobindo Pharma to commercialise China plant in third quarter of FY25: CFO
Aurobindo Pharma arm gets warning letter from USFDA for formulations unit in Telangana
Aurobindo Pharma commissions four plants in Andhra Pradesh including Pen-G facility
Aurobindo Pharma shares tumble nearly 7 pc in early trade; hit 52-week low after Q2 earnings
Aurobindo Pharma arm gets final USFDA nod for Vasopressin injection